ArticleBioImpacts : BI2025

An efficacious opportunity for diagnosis and treatment of cancers: Radiolabeled fibroblast activation protein (FAP) inhibitors.

Nasim Vahidfar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.